BriefTea
Every story in sixty words
Explained in plain English
The experimental drug intismeran is a collaboration between two major pharmaceutical companies: Merck and Moderna. Merck is a global healthcare company, and Moderna is well-known for its mRNA vaccine technology. Their partnership combines their expertise to develop this personalised mRNA vaccine for melanoma patients.
Stories that explain this
Experimental mRNA drug stops skin cancer returning after surgery